Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss

European Journal of Ophthalmology

Volumn 21, Issue 1, 2011, Pages 24-29

  Moschos, Marilita M ^a   Tagaris, Georgios ^b   Markopoulos, Ioannis ^a   Margetis, Ioannis ^a   Tsapakis, Stylianos ^a   Kanakis, Menelaos ^a   Koutsandrea, Chrysanthi ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

Macula; Multifocal electroretinogram; Optical coherence tomography; Parkinson disease

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; CLINICAL ARTICLE; COLOR VISION; CONTROLLED STUDY; EARLY DIAGNOSIS; ELECTRORETINOGRAPHY; FEMALE; HUMAN; MALE; NERVE FIBER; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RETINA DISEASE; RETINA FOVEA; SENSORY NERVE; SENSORY NERVE CONDUCTION; SENSORY SYSTEM ELECTROPHYSIOLOGY; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

COLOR VISION; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; PARKINSON DISEASE; PILOT PROJECTS; RETINA; RETINAL DISEASES; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS; VISUALLY IMPAIRED PERSONS;

EID: 78650680556     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/EJO.2010.1318     Document Type: Article

References (29)

1. Barbeau A, Campanella G, Butterworth R, Yamada K. Uptake and efflux of 14C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease. Neurology 1975; 25: 1-9.
2. Jackson RG, Owsley C. Visual dysfunction, neurodegenerative diseases and aging. Neurol Clin North Am 2003; 21: 709-28.
3. Bodis-Wollner I, Yahr MD. Measurements of the visual evoked potentials in Parkinson's disease. Brain 1978; 101: 661-71.
4. Delwaide PJ, Mesraoua B, De Pasqua V. Les potentiels évoqué s visuels dans la maladie de Parkinson. Rev Electroencephalogr Neurophysiol Clin 1980; 10: 338-42.
5. Gawel MJ, Vincent S, Clifford RF. Visual evoked potentials in patients with Parkinson disease. J Neurol Neurosurg Psychiatry 1981; 44: 227-32.
6. Gottlob I, Weghaupt H, Vass C, Auff E. Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials. Graefes Arch Clin Exp Ophthalmol 1989; 227: 421-7.
7. Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res 1994; 34: 2629-38.
8. Sutter EE, Tran D. The field topography of ERG components in man: I: the photopic luminance response. Vision Res 1992; 32: 433-46.
9. Kondo M, Miyake Y, Horiguchi M, et al. Clinical assessment of multifocal electroretinogram. Invest Ophthalmol Vis Sci 1995; 36: 2146-50.
10. Langheinrich T, Tebartz van Elst L, Lagreze WA, Lucknig HC, Greenlee NW. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visual evoked potentials and psychophysics. Clin Neurophysiol 2000; 11: 66-74.
11. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson's disease. Vision Res 2004; 44: 2793-7.
12. Hajee ME, March WF, Lazzaro DR, et al. EH Inner retinal layer thinning in Parkinson's disease. Arch Ophthalmol 2009; 127: 737-41.
13. Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical multifocal electroretinography. Doc Ophthalmol 2008; 116: 1-11.
14. Bodis-Wollner I, Marx M, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Brain 1987; 110: 1675-98.
15. Jaffe MJ, Bruno G, Campbell G, Lavine RA, Karson NC, Weinberger DR. Ganzfield electroretinographic findings in Parkinsonism: untreated patients and the effect of levodopa intravenous infusion. J Neurol Neurosurg Psychiatry 1987; 50: 847-52.
16. Haggendal J, Malmfors T. Evidence of dopamine containing neurons in the retina of the rabbit. Acta Physiol Scand 1963; 64: 58-66.
17. Harnois C, Di Paolo T. Decrease dopamine in the retina's of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 1990; 31: 2473-5.
18. Brown KT. The electroretinogram its components and their origins. Vision Res 1968; 8: 633-77.
19. Heynen H, Van Norren D. Origin of electroretinogram in the intact macaque eye: I: principal component analysis. Vision Res 1985; 25: 697-707.
20. Brann MR, Jelsema CL. Dopamine receptors on photoreceptors membranes couple to a DGT binding protein which is sensitive to both pertussis and cholera toxin. Biochem Biophys Res Commun 1985; 133: 222-7.
21. Dearry A, Burnside B. Dopamine inhibits Forskolin- and 3-isobutyl-l-methylxanthine-induced dark-adaptive retinomotor movements in isolated teleost retinae. J Neurochem 1985; 44: 1753-63.
22. Dyer RS, Howell WE, MacPhail RC. Dopamine depletion slows retinal transmissions. Exp Neurol 1981; 71: 326-40.
23. Peppe A, Stanzione P, Pierelli F, et al. Low contrast stimuli enhance PERG sensitivity to the visual dysfunction in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1992; 82: 453-7.
24. Peppe A, Stanzione P, Pierelli F, et al. Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology 1995; 45: 1144-8.
25. Palmowski-Wolfe AM, Perez MT, Behnke S, et al. Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG. Doc Ophthalmol 2006; 112: 209-15.
26. Archibald NK, Clarke MP, Mosimanmn UP, Burn DJ. The retina in Parkinson's disease. Brain 2009; 132: 1128-45.
27. Bodis-Wollner I, Hendley CD, Kulikowsky JJ. Electrophysiological and psychophysical responses to modulation of contrast of grating patterns. Perception 1972; 1: 341-9.
28. Nir I, Harrison JM, Haque B, et al. Dysfunctional light evoked regulation of CAMP in photoreceptors and abnormal retinal adaptation in mice lacking dopamine D4 receptors. J Neurosci 2002; 22: 2063-73.
29. Bodis-Wollner I. Diagnosing and treating early: is there a precardinal stage of Parkinson disease? Parkinson Rep 2008; 19: 9-10.